Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Almirall logo — Is an international pharmaceutical company based on innovati...

Almirall

Is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain

Founded 1943 Spain Spain 2441 employees IPO Total: $450.00M

General Information

Company Name Almirall
Founded Year 1943
Location Spain Spain +3
Employees 2441
Funding Stage IPO
Social

Get notified when Almirall moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Aug 12, 2026

Hiring for 48 positions in the last 30 days.

Get alerts when Almirall shows new signals

About Almirall

Almirall is a prominent global biopharmaceutical company founded in 1944 and headquartered in Barcelona, Spain. The company specializes in medical dermatology and is recognized for its commitment to innovation and transforming the lives of patients worldwide.

Their core focus lies in the development and commercialization of solutions for dermatological diseases such as psoriasis, actinic keratosis, atopic dermatitis, and acne. This focus is reinforced by significant investment in R&D and strategic global healthcare partnerships. With a robust infrastructure that includes 1 R&D center, 2 chemical plants, and 2 pharmaceutical plants, Almirall distributes treatments in over 100 countries via 15 global affiliates.

The company recently attracted attention with a €250.00M Post Ipo Debt investment on 01 December 2025. Being publicly listed on the Spanish Stock Exchange (ticker: ALM) underscores its strong market presence and potential appeal for future investors.

Taxonomy: Pharmaceutical Innovation, Medical Dermatology, Psoriasis Treatment, Actinic Keratosis Solutions, Atopic Dermatitis Treatment, Acne Solutions, Clinical Research and Development, Global Healthcare Partnerships, Biopharmaceutical Solutions, Inflammatory Skin Conditions, Dermatology Focus, Specialty Pharmaceuticals, R&D Investment, Multiple Sclerosis Spasticity

Services & Products

Research and Development
Clinical Trials
Patient Care Support
Sustainability Initiatives
Pipeline Innovation

Target Customers

Patients with Skin Conditions Healthcare Professionals Investors Medical Researchers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Debt •••••• - 01 Dec 2025
Post Ipo Equity •••••• 1
Investor
01 Jun 2023
Acquisition •••••• 1 •••• •••• 01 Jul 2014
IPO •••••• - 01 Jun 2007

Almirall Alternatives & Competitors

View All Alternatives
Almirall vs
Aqua Pharmaceuticals, an Almirall Company
Aqua Pharmaceuticals, an Almirall Company United States

Aqua Pharmaceuticals is a specialty dermatology company focusing on acquiring, developing and market...

55 employees
Biotechnology
Almirall vs
Vectura Group
Vectura Group United Kingdom

We are a specialist inhalation CDMO helping you bring innovative inhaled medicines to market.

Unknown
238 employees
Compare Almirall vs Vectura Group
Almirall vs
Daavlin Phototherapy
Daavlin Phototherapy United States

The Professionals Choice for Phototherapy Solutions.

50 employees
Health Care, Medical Devices
Compare Almirall vs Daavlin Phototherapy
Also compare with: Almirall vs Innovis Pharma Innovis Pharma View all alternatives

FAQ About Almirall

Is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain
Almirall was founded in 1943.
Almirall is headquartered in Spain.
Almirall has approximately 2441 employees.
Almirall has completed 4 funding rounds, raising a total of $450.00M. The latest funding stage is IPO.
Almirall offers: Research and Development, Clinical Trials, Patient Care Support, Sustainability Initiatives, Pipeline Innovation.
Top alternatives and competitors to Almirall include Aqua Pharmaceuticals, an Almirall Company, Vectura Group, Daavlin Phototherapy, Innovis Pharma, DermatologistOnCall. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Almirall and Aqua Pharmaceuticals, an Almirall Company are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Almirall and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy